Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin ...

Being a recombinant variant also means it gets that weird XBB name; non-recombinant variants — which have straightforward lineages to previous versions of SARS-CoV-2 — are given names like BA ...

Nov. 15, 2017 /PRNewswire/ -- Available for immediate shipment from Applied Biotechnology Institute (ABI) (www.appliedbiotech.org), is TRYPZEAN®, the leading non-animal recombinant alternative to ...

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

AMSBIO announces a new range of recombinant proteins that can substitute extracellular matrix proteins that are currently extracted from mouse sarcoma. ... Non-Animal Recombinant Proteins for Cell ...

Non-replicating vaccines are based on recombinant viral vectors that are made replication non-competent, meaning that these vectors are sufficient to induce host immune responses but cannot ...

A virion containing a recombinant genome can infect nearby cells due to the surface proteins produced during the previous cell's infection by non-recombinant parental RNAs.